KUALA LUMPUR, Sept 6 (Bernama) -- PHC Holdings Corporation (PHCHD), a leading global life science, diagnostics and medical device company, has announced the appointment of William (Bill) Donnelly and Ivan Tornos as independent external directors, effective Sept 3.
Donnelly joins the board with almost 25 years’ experience in the laboratory equipment industry, having been most recently the Executive Vice President responsible for Finance, Supply Chain, Manufacturing and IT for Mettler-Toledo.
He started his career working as an auditor for Price Waterhouse for 10 years, and is currently an Independent Director of Ingersoll Rand and PST, as well as the Board Chair for John Carroll University.
Tornos, who joins the board with almost 25 years’ experience in the medical device industry, is currently Chief Operating Officer at Zimmer Biomet, responsible for overseeing all global businesses and leading the global operations, clinical and medical education, and global R&D functions.
In a statement, PHCHD President, CEO and Chairman of the Board of Directors, John Marotta said: "I am thrilled to have Bill and Ivan join the PHC Holdings Board of Directors. These are two exceptional industry leaders who will add vast experience and capabilities to our board.”
“Bill and Ivan’s industry knowledge and strategic guidance will be immensely valuable to the future success of the PHC Group."
The addition of these new independent external directors follows the recent appointment of Alan Malus and Kyoko (Kay) Deguchi in July.
Headquartered in Minato-ku, Tokyo, Japan, PHCHD is a global healthcare company with subsidiaries including PHC Corporation, Ascensia Diabetes Care, Epredia, and LSI Medience Corporation.
For more information, visit www.phchd.com
-- BERNAMA
No comments:
Post a Comment